The obstructive sleep apnea syndrome is typically associated with conditions known to
increase insulin resistance as hypertension, obesity, and diabetes. We investigated whether …

Background We recently demonstrated that continuous positive airway pressure (CPAP)
therapy rapidly improves insulin sensitivity within 2 days in non-diabetic patients with …

Background: The obstructive sleep apnoea syndrome (OSA) is a frequent condition, as well
as type 2 diabetes mellitus. Both diseases are characterized by insulin resistance …

The effects of treatment of obstructive sleep apnoea (OSA) on glucose metabolism have
been investigated previously with conflicting results. This study evaluated the impact of …

Abstract Study Objectives: Obstructive sleep apnea (OSA) is associated with an increased
prevalence of metabolic syndrome (MetS), even in patients with morbid obesity. Our goal …

Objective: We investigated glucose metabolism and insulin resistance in non-obese and
moderately overweight sleep apnea patients, as well as their response to nasal CPAP …

Rationale: Obstructive sleep apnea (OSA) is an independent risk factor for the development
of insulin resistance (IR). Treatment with continuous positive airway pressure (CPAP) for …

Obstructive sleep apnea (OSA) is independently associated with glucose intolerance and
insulin resistance, and recent studies have shown that continuous positive airway pressure …

Background Obstructive sleep apnea (OSA) is associated with obesity, insulin resistance
(IR) and diabetes. Continuous positive airway pressure (CPAP) rapidly mitigates OSA in …

Patients with noninsulin-dependent diabetes mellitus (NIDDM) are often obese and
frequently complain of tiredness. These features are also characteristically seen in patients …